Home / News / Global Pain Management Drugs And Devices Market is expected to reach $50.76 billion by 2022 – Brisk Insights

Global Pain Management Drugs And Devices Market is expected to reach $50.76 billion by 2022 – Brisk Insights

According to a recently published report the Pain Management Drugs And Devices Market was estimated to grow around $37.8 billion in 2015and it is forecasted to reach around $50.76 billion at a CAGR of 4.3% during 2015-2022. The segmentation of pain management drugs and devices market is based on product type, drug class, and indication and by geography. The report on pain management drugs and devices market forecast 2015-2022 (by product type, drug class, and indication and geography) provides detailed summary as well as predictive analysis of the market.

Full report is available on global pain management drugs and devices market forecast 2015-2022 (byproduct type, drug class, and indication and geography)report at http://www.briskinsights.com/report/pain-management-drugs-and-devices-market

Rising prevalence of chronic diseases in all over the world is a key driver for the pain management drugs and devices market. The main reason is increasing number of chronic pain disorders such as migraine, chronic back pain, cancer pain and others which is directly boosting the demand for pain management drugs and devices.There is an increasing focus on high investment by various end users industries due to increasing number of hospitals and rising favorable government initiatives which are expected to fuel the pain management drugs and devices market.The another major factor which drives the market is the rising geriatric population which helps in increasing the demand for this market.The pain management drugs and devices market also helps in reducing the long stay of a patient in the hospital and act as a major driver for global pain management drugs and devices market.
These are the major factors which help in boosting the pain management drugs and devices market. Some of the challenges that are to be faced by the pain management drugs and devices market are stringent regulatory guidelines and lack of novel therapeutics for pain management which immensely affects the pain management drugs and device market globally. The major restraints of this market are high competition among key players and dearth of experienced and skilled personnel that directly impacts and hinders the growth rate of pain management drugs and devices market.
Scope of the report

1. Global Pain Management Drugs And Devices Market By Product Type2012 – 2022 ($ Billion)
1.1. Electrical stimulation devices
1.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
1.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
1.1.3. Other Electrical Stimulation Devices
1.1.3.1. Electrotherapy Devices
1.1.3.2. Combination Devices
1.1.3.3. TNS
1.1.3.4. TMS
1.2. Radiofrequency ablation devices
1.3. Analgesic infusion pumps
1.3.1. Intrathecal Infusion Pumps
1.3.2. External Infusion Pumps
1.4. Neuro-stimulation devices
1.4.1. Spinal Cord Stimulation (SCS) Devices
1.4.2. Deep Brain Stimulation Devices
1.4.3. Vagus Nerve Stimulation Devices
1.4.4. Sacral Nerve Stimulation Devices

2. Global Pain Management DrugsAnd DevicesMarketBy Drug Class 2012 – 2022 ($ Billion)
2.1.1. NSAIDS
2.1.2. Anesthetics
2.1.3. Anticovulsants
2.1.4. Anti-Migraine Agents
2.1.5. Antidepressent
2.1.6. Opioids
2.1.7. Non-Narcotic Analgesics

3. Global Pain Management DrugsAnd DevicesMarket By Indications 2012 – 2022 ($ Billion)
3.1. Arthritic pain
3.2. Neuropathic pain
3.3. Cancer pain’
3.4. Chronic back pain
3.5. Post-operative pain
3.6. Migraine
3.7. Fibromyalgia

4. Global Pain Management DrugsAnd Devices MarketRegional Outlook 2012-2022 ($ Billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest Of The World

5. Company Profile
5.1. AstraZeneca PLC
5.2. Baxter International Inc.
5.3. Boston Scientific Corporation
5.4. Eli Lilly
5.5. Endo Health Solutions
5.6. Forest Laboratories
5.7. Halyard Inc.
5.8. Johnson & Johnson
5.9. Medtronic plc
5.10. Pfizer Inc
5.11. Purdue Pharma
5.12. Smiths Medical
5.13. St. Jude Medical
5.14. Stryker Corporation
5.15. Teva Pharmaceuticals (Cephalon, Inc.)

Global Pain Management Drugs And Devices Market is expected to reach $50.76 billion by 2022 – Brisk Insights reviewed on July 6, 2016 by rated 5.0 of 5

Release ID: 2168

About Manju Chandra

Check Also

400-400

Global Carbon Nanofiber Market Size, Share, Growth, Outlook, strategies and Forecast to 2016: Acute Market Reports

Notes: Production, means the output of Carbon Nanofiber Revenue, means the sales value of Carbon ...